ICO
834265032
Web
Sign in to see organisation website
Address
ATLANTA
Homepage | VIP Consortium Transforming Higher Education Worldwide Transforming Higher Education Worldwide VIP Consortium is a global nonprofit alliance of colleges and universities that operate Vertically Integrated Projects VIP programs. We provide the ecosystem that supports the expansion success promotion and implementation of VIP worldwide. What are Vertically Integrated Projects. Vertically Integrated Projects VIP teams engage students in longterm largescale multidisciplinary research as they work alongside faculty and graduate students to solve realworld challenges.
From Social media
News about from their social media (Facebook and X).
Data about organisation
ATLANTA
Organisations from VIP CONSORTIUM INC
A global initiative defending the ecosystems that produce our oxygen.
3. American Cancer Society Foundation
For cancer information, call 1-800-227-2345 or visit cancer.
4. American Cancer Society Inc
For cancer information, call 1-800-227-2345 or visit cancer.
For cancer information, call 1-800-227-2345 or visit cancer.
Similar organisations
Similar organisations to VIP CONSORTIUM INC based on mission, location, activites.
MECKLENBURG CITIZENS FOR PUBLIC EDUCATION
MeckEd is an independent, nonpartisan nonprofit and champion for excellent public education for all.
An equitable Atlanta school board by 2025.
Similar Organisations Worldwide
Organisations in the world similar to VIP CONSORTIUM INC.
We are driving change in education; empowering regional communities to fulfil their potential.
A global community of not-for-profit organisations advancing human development worldwide.
Interesting nearby
Interesting organisations close by to residence of VIP CONSORTIUM INC
Southern Education Foundation, Inc
The Southern Education Foundation works to improve education in the South.
An equitable Atlanta school board by 2025.
Join us and make a difference for the future!
Sign Up
Please fill in your information. Everything is free, we might contact you with updates (but cancel any time!)
Sign in with GoogleOr
Good News
Exciting news from ITM! π Their Phase 3 COMPETE trial shows promising results for n.c.a. 177Lu-edotreotide, offering hope for patients with GEP-NETs. Together, we're witnessing advancements in healthcare that make a real difference! πͺπ #CancerResearch #Hope #PositiveNews
ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025
StreetInsider.com
Like Comment